Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis
- PMID: 7883225
- PMCID: PMC1382412
- DOI: 10.1136/gut.36.2.251
Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis
Abstract
Patients with familial adenomatous polyposis (FAP) and age and sex matched controls were tested for cytochrome P4501A2 (CYP1A2), N-acetyltransferase, and xanthine oxidase activities using caffeine urinary metabolites as a discriminator. FAP patients showed significant underactivity of N-acetyltransferase (which inactivates some carcinogens) and significant overactivity of CYP1A2 (which activates some carcinogens). Xanthine oxidase activity, which can generate free radicals and cause cellular damage, was significantly increased in the FAP patients. All but one of the FAP patients had undergone colectomy. A separate group of six patients was therefore assessed before and at an average time of eight weeks after colectomy. No effect on enzyme activity was seen. The differences in enzyme activities detected in this study could produce an excess of active carcinogenic metabolites in the bile of FAP patients and contribute to the high risk for intestinal cancer in FAP.
Comment in
-
Caffeine phenotyping in patients with familial adenomatous polyposis may shed light on sporadic colon cancer and acetylator status.Gut. 1996 Jan;38(1):153. doi: 10.1136/gut.38.1.153. Gut. 1996. PMID: 8566846 Free PMC article. No abstract available.
Similar articles
-
Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.Ther Drug Monit. 1996 Jun;18(3):254-62. doi: 10.1097/00007691-199606000-00006. Ther Drug Monit. 1996. PMID: 8738764 Clinical Trial.
-
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".Clin Pharmacol Ther. 2000 Oct;68(4):375-83. doi: 10.1067/mcp.2000.109519. Clin Pharmacol Ther. 2000. PMID: 11061577
-
Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.Clin Pharmacol Ther. 1992 Dec;52(6):643-58. doi: 10.1038/clpt.1992.203. Clin Pharmacol Ther. 1992. PMID: 1458773
-
The use of caffeine as a metabolic probe for human drug metabolizing enzymes.Gen Pharmacol. 1996 Mar;27(2):245-9. doi: 10.1016/0306-3623(95)02014-4. Gen Pharmacol. 1996. PMID: 8919637 Review.
-
[Preventive surgery for familial adenomatous polyposis coli].Chirurg. 2005 Dec;76(12):1125-34. doi: 10.1007/s00104-005-1115-x. Chirurg. 2005. PMID: 16323029 Review. German.
Cited by
-
Gastroduodenal lesions in familial adenomatous polyposis.Surg Today. 2000;30(8):675-82. doi: 10.1007/s005950070077. Surg Today. 2000. PMID: 10955728 Review.
-
Human colonocyte detoxification.Gut. 1997 Dec;41(6):731-4. doi: 10.1136/gut.41.6.731. Gut. 1997. PMID: 9462203 Free PMC article. Review. No abstract available.
-
Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.Br J Clin Pharmacol. 2003 Jan;55(1):68-76. doi: 10.1046/j.1365-2125.2003.01733.x. Br J Clin Pharmacol. 2003. PMID: 12534642 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous